Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (41)

2023

  1. The black hole of the transition process: dropout of care before transition age in adolescents

    European Child and Adolescent Psychiatry, Vol. 32, Núm. 7, pp. 1285-1295

2021

  1. A systematic review of magnetic resonance imaging studies in perinatally HIV-infected individuals

    AIDS Reviews, Vol. 23, Núm. 4, pp. 167-185

  2. Effectiveness of tianeptine in patients with m ajor depression and substance-related disorders

    Actas Espanolas de Psiquiatria, Vol. 49, Núm. 4, pp. 135-144

  3. Predicting conversion to multiple sclerosis by assessing cognitive impairment in radiologically isolated syndrome

    Multiple Sclerosis and Related Disorders

  4. The interplay between functioning problems and symptoms in first episode of psychosis: An approach from network analysis

    Journal of Psychiatric Research, Vol. 136, pp. 265-273

  5. The role of premorbid iq and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis

    Journal of Clinical Medicine, Vol. 10, Núm. 11

2020

  1. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases

    Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260

  2. Brain functional connectivity after cognitive-bias modification and behavioral changes in abstinent alcohol-use disorder patients

    International Journal of Psychophysiology, Vol. 154, pp. 46-58

  3. Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study (Drugs - Real World Outcomes, (2020), 7, 1, (75-83), 10.1007/s40801-020-00178-8)

    Drugs - Real World Outcomes

  4. Neuropsychophysiological Measures of Alcohol Dependence: Can We Use EEG in the Clinical Assessment?

    Frontiers in Psychiatry, Vol. 11

  5. Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

    Drugs - Real World Outcomes, Vol. 7, Núm. 1, pp. 75-83

2019

  1. Coexistence between personality disorders and substance use disorder. Madrid study about prevalence of dual pathology

    Actas Espanolas de Psiquiatria, Vol. 47, Núm. 5, pp. 218-228

2018

  1. Adherence, insight and disability in paranoid schizophrenia

    Psychiatry Research, Vol. 270, pp. 274-280

  2. Alteraciones neuropsicológicas en la narcolepsia con cataplejía: Una revisión

    Revista de Neurologia, Vol. 66, Núm. 3, pp. 89-96

  3. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711

  4. Personality organization and its association with clinical and functional features in borderline personality disorder

    Psychiatry Research, Vol. 262, pp. 393-399

2017

  1. Individual differences in the dominance of interhemispheric connections predict cognitive ability beyond sex and brain size

    NeuroImage, Vol. 155, pp. 234-244

  2. Influence of attention deficit hyperactivity disorder symptoms on quality of life and functionality in adults with eating disorders

    Actas Espanolas de Psiquiatria, Vol. 45, Núm. 3, pp. 98-107

  3. Insular pathology in young people with high-functioning autism and first-episode psychosis

    Psychological Medicine, Vol. 47, Núm. 14, pp. 2472-2482

  4. Madrid Study (Spain) on the Prevalence and Characteristics of Outpatients with Dual Disorders

    Addictive Disorders and their Treatment, Vol. 16, Núm. 4, pp. 187-200